You are viewing an incomplete version of our website. Please click to reload the website as full version.

HER2 antibody (V-Erb-B2 erythroblastic Leukemia Viral Oncogene Homolog 2, Neuro/glioblastoma Derived Oncogene Homolog (Avian)) (C-Term)

Details for Product anti-ERBB2 Antibody No. ABIN499802, Supplier: Log in to see
Antigen
  • CD340
  • HER-2
  • HER-2/neu
  • HER2
  • MLN 19
  • NEU
  • NGL
  • TKR1
  • Erbb-2
  • Neu
  • c-erbB2
  • c-neu
  • mKIAA3023
  • v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog
  • v-erb-b2 avian erythroblastic leukemia viral oncogene 2
  • v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2
  • v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)
  • ERBB2
  • Erbb2
Alternatives
anti-Human HER2 antibody for Western Blotting
Epitope
C-Term
99
82
70
63
56
53
52
46
44
35
27
23
22
21
21
21
21
20
20
20
20
20
20
19
19
19
18
16
15
14
13
13
12
12
10
8
8
8
8
8
7
7
7
6
6
6
5
5
4
4
4
4
4
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Reactivity
Human, Mouse (Murine), Rat (Rattus)
1354
498
332
35
34
15
13
8
6
5
4
3
3
3
2
1
1
1
1
1
Host
Chicken
996
503
29
16
10
5
1
Clonality
Polyclonal
Conjugate
This HER2 antibody is un-conjugated
73
64
60
54
45
41
18
18
10
10
10
9
9
8
8
8
8
8
8
7
7
7
7
7
7
7
7
6
3
2
2
Application
Enzyme Immunoassay (EIA), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Western Blotting (WB)
705
609
327
322
308
298
239
128
111
102
87
21
16
14
6
5
5
5
5
3
3
3
3
2
2
1
1
1
1
Options
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Get this product for free

It's quick and easy to submit your validation proposal. I want to validate this product

Learn more

Available images

Immunogen erbB-2 antibody was raised against a 19 amino acid peptide near the carboxy terminus of human erbB-2.
Isotype IgG
Specificity This antibody reacts to erbB-2.
Purification Affinity chromatography purified via peptide column
Alternative Name CD340 / ERBB2 / HER2 (ERBB2 Antibody Abstract)
Background The ErbB family consists of four closely related tyrosine kinase receptors that act as potent mediators of normal cell growth and development. Aberrant expression or function of one or more of these receptors can play a major role in the development and evolution of cancer. ErbB-2, also known as HER2, has been implicated in the evolution of both breast and gastric cancers, and is evident in other cancer types such as ovarian and salivary gland tumors. ErbB-2 possesses an active tyrosine kinase domain, but no direct ligand has been identified yet. ErbB-2 is the preferred binding partner to the other members of the ErbB family and is thought to act primarily through the Ras-MAPK, PI3k-PKB/Akt, and PLC-PKC signaling pathways. Numerous anti-cancer strategies have been employed against erbB-2, such as antibody-based therapies to prevent ligand binding or receptor activation through dimerization, antibody-dependent cell mediated cytotoxicity, in addition to direct kinase inhibition to prevent molecular activation/downstream signaling.Synonyms: HER-2, MNL19, NEU, NEU proto-oncogene, NGL, Receptor tyrosine-protein kinase erbB-2, Tyrosine kinase-type cell surface receptor HER2, c-erbB-2, p185erbB2
Gene ID 2064
NCBI Accession NP_004439
UniProt P04626
Pathways RTK Signaling, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway
Application Notes ELISA. Western Blot: 1 - 2 μg/mL. Immunohistochemistry.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.
Restrictions For Research Use only
Buffer PBS containing 0.02 % sodium azide.
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage 4 °C
Storage Comment Store the antibody undiluted at 2-8 °C.
Supplier Images
Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)) image for anti-HER2 antibody (V-Erb-B2 erythroblastic Leukemia Viral Oncogene Homolog 2, Neuro/glioblastoma Derived Oncogene Homolog (Avian)) (C-Term) (ABIN499802) Immunohistochemistry of erbB-2 in human liver tissue with erbB-2 antibody at 2.5 μg/ml.
Western Blotting (WB) image for anti-HER2 antibody (V-Erb-B2 erythroblastic Leukemia Viral Oncogene Homolog 2, Neuro/glioblastoma Derived Oncogene Homolog (Avian)) (C-Term) (ABIN499802) Western blot analysis of erbB-2 in rat liver tissue lysate with AP30319PU-N erbB-2 an...
Background publications Baselga, Swain: "Novel anticancer targets: revisiting ERBB2 and discovering ERBB3." in: Nature reviews. Cancer, Vol. 9, Issue 7, pp. 463-75, 2009 (PubMed).

Vermeij, Teugels, Bourgain, Xiangming, in t Veld, Ghislain, Neyns, De Grève: "Genomic activation of the EGFR and HER2-neu genes in a significant proportion of invasive epithelial ovarian cancers." in: BMC cancer, Vol. 8, pp. 3, 2008 (PubMed).

Manno: "Measurement of the digit lengths and the anogenital distance in mice." in: Physiology & behavior, Vol. 93, Issue 1-2, pp. 364-8, 2008 (PubMed).

Marmor, Skaria, Yarden: "Signal transduction and oncogenesis by ErbB/HER receptors." in: International journal of radiation oncology, biology, physics, Vol. 58, Issue 3, pp. 903-13, 2004 (PubMed).

Slamon, Clark, Wong, Levin, Ullrich, McGuire: "Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene." in: Science (New York, N.Y.), Vol. 235, Issue 4785, pp. 177-82, 1987 (PubMed).